Muralidharan Bhavana, Keruzore Marc, Pradhan Saurabh J, Roy Basabdatta, Shetty Ashwin S, Kinare Veena, D'Souza Leora, Maheshwari Upasana, Karmodiya Krishanpal, Suresh Agasthya, Galande Sanjeev, Bellefroid Eric J, Tole Shubha
Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai 400 005, India.
Université Libre de Bruxelles (ULB), ULB Institute of Neuroscience, B-6041 Gosselies, Belgium.
J Neurosci. 2017 Nov 15;37(46):11245-11254. doi: 10.1523/JNEUROSCI.1535-17.2017. Epub 2017 Oct 12.
Regulation of the neuron-glia cell-fate switch is a critical step in the development of the CNS. Previously, we demonstrated that Lhx2 is a necessary and sufficient regulator of this process in the mouse hippocampal primordium, such that Lhx2 overexpression promotes neurogenesis and suppresses gliogenesis, whereas loss of Lhx2 has the opposite effect. We tested a series of transcription factors for their ability to mimic Lhx2 overexpression and suppress baseline gliogenesis, and also to compensate for loss of Lhx2 and suppress the resulting enhanced level of gliogenesis in the hippocampus. Here, we demonstrate a novel function of Dmrt5/Dmrta2 as a neurogenic factor in the developing hippocampus. We show that Dmrt5, as well as known neurogenic factors Neurog2 and Pax6, can each not only mimic overexpression, but also can compensate for loss of Lhx2 to different extents. We further uncover a reciprocal regulatory relationship between Dmrt5 and Lhx2, such that each can compensate for loss of the other. Dmrt5 and Lhx2 also have opposing regulatory control on and , indicating a complex bidirectionally regulated network that controls the neuron-glia cell-fate switch. We identify Dmrt5 as a novel regulator of the neuron-glia cell-fate switch in the developing hippocampus. We demonstrate Dmrt5 to be neurogenic, and reciprocally regulated by Lhx2: loss of either factor promotes gliogenesis; overexpression of either factor suppresses gliogenesis and promotes neurogenesis; each can substitute for loss of the other. Furthermore, each factor has opposing effects on established neurogenic genes and Dmrt5 is known to suppress their expression, and we show that Lhx2 is required to maintain it. Our study reveals a complex regulatory network with bidirectional control of a fundamental feature of CNS development, the control of the production of neurons versus astroglia in the developing hippocampus.Finally, we confirm that Lhx2 binds a highly conserved putative enhancer of , suggesting an evolutionarily conserved regulatory relationship between these factors. Our findings uncover a complex network that involves Lhx2, Dmrt5, Neurog2, and Pax6, and that ensures the appropriate amount and timing of neurogenesis and gliogenesis in the developing hippocampus.
神经元 - 神经胶质细胞命运转换的调控是中枢神经系统发育中的关键步骤。此前,我们证明Lhx2是小鼠海马原基中这一过程的必要且充分的调节因子,即Lhx2过表达促进神经发生并抑制胶质细胞生成,而Lhx2缺失则产生相反的效果。我们测试了一系列转录因子模拟Lhx2过表达并抑制基线胶质细胞生成的能力,以及补偿Lhx2缺失并抑制海马体中由此产生的增强的胶质细胞生成水平的能力。在此,我们证明了Dmrt5 / Dmrta2在发育中的海马体中作为神经发生因子的新功能。我们表明,Dmrt5以及已知的神经发生因子Neurog2和Pax6不仅各自能够模拟过表达,而且还能在不同程度上补偿Lhx2的缺失。我们进一步揭示了Dmrt5和Lhx2之间的相互调节关系,即彼此都能补偿对方缺失所产生的影响。Dmrt5和Lhx2对 和 也具有相反的调控作用,这表明存在一个控制神经元 - 神经胶质细胞命运转换的复杂双向调控网络。我们确定Dmrt5是发育中的海马体中神经元 - 神经胶质细胞命运转换的新型调节因子。我们证明Dmrt5具有神经发生作用,并与Lhx2相互调节:任一因子缺失都会促进胶质细胞生成;任一因子过表达都会抑制胶质细胞生成并促进神经发生;彼此都能替代对方缺失的作用。此外,每个因子对已确定的神经发生基因 和 都有相反的影响,已知Dmrt5会抑制它们的表达,我们表明Lhx2是维持这种抑制作用所必需的。我们的研究揭示了一个复杂的调控网络,对中枢神经系统发育的一个基本特征进行双向控制,即在发育中的海马体中控制神经元与星形胶质细胞的产生。最后,我们证实Lhx2结合了 的一个高度保守的假定增强子,表明这些因子之间存在进化上保守的调控关系。我们的研究结果揭示了一个涉及Lhx2、Dmrt5、Neurog2和Pax6的复杂网络,该网络确保了发育中的海马体中神经发生和胶质细胞生成的适当数量和时机。